Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2024 Financial Results

Rhea-AI Summary

Artivion (NYSE: AORT) has scheduled its third quarter 2024 financial results release for Thursday, November 7, 2024, after market close. The company will host a teleconference call and live webcast at 4:30 p.m. ET, featuring a Q&A session with Chairman, President and CEO Pat Mackin. Participants can dial 201-689-8261 to join the call. A replay will be available at 877-660-6853 or 201-612-7415 with conference number 13748263. The webcast and earnings press release will be accessible through the Investors section of Artivion's website.

ATLANTA, Oct. 24, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that third quarter 2024 financial results will be released on Thursday, November 7, 2024 after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results, followed by a question and answer session hosted by Pat Mackin, Chairman, President and Chief Executive Officer of Artivion.

To listen to the live teleconference, please dial 201-689-8261 a few minutes prior to 4:30 p.m. ET. The teleconference replay will be available approximately one hour following the completion of the event and can be accessed by calling (toll free) 877-660-6853 or 201-612-7415. The conference number for the replay is 13748263. 

The live webcast and replay can be accessed on the Investors section of the Artivion website at www.artivion.com and by selecting Webcasts & Presentations. In addition, a copy of the earnings press release, which will contain financial and statistical information for the completed quarter and full year, can be accessed in the Investors section of the Artivion website.

About Artivion, Inc.
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com.

Contacts:

Artivion Lance A. Berry Executive Vice President & Chief Financial Officer  Phone: 770-419-3355

Gilmartin Group LLC Brian Johnston / Laine Morgan Phone: 332-895-3222 investors@artivion.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-announces-release-date-and-teleconference-call-details-for-third-quarter-2024-financial-results-302286565.html

SOURCE Artivion, Inc.

FAQ

When will Artivion (AORT) release Q3 2024 earnings?

Artivion will release its Q3 2024 financial results on Thursday, November 7, 2024, after market close.

What time is Artivion's (AORT) Q3 2024 earnings call?

Artivion's Q3 2024 earnings call is scheduled for 4:30 p.m. ET on Thursday, November 7, 2024.

How can I listen to Artivion's (AORT) Q3 2024 earnings call?

You can dial 201-689-8261 for the live call, or access the webcast through the Investors section at www.artivion.com.